Early tumor shrinkage as a predictor of favorable outcomes in patients with advanced pancreatic cancer treated with FOLFIRINOX

There are several reports on the correlation between early tumor shrinkage (ETS) or depth of response (DpR) and survival in chemotherapies for colorectal cancer; however, few studies have investigated it in pancreatic cancer. We therefore investigated whether the ETS will predict outcomes in 59 pati...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Oncotarget Ročník 7; číslo 41; s. 67314 - 67320
Hlavní autoři:	Kaga, Yasuhiro, Sunakawa, Yu, Kubota, Yutaro, Tagawa, Teppei, Yamamoto, Taikan, Ikusue, Toshikazu, Uto, Yu, Miyashita, Kouichirou, Toshima, Hirokazu, Kobayashi, Kouji, Hisamatsu, Atsushi, Ichikawa, Wataru, Sekikawa, Takashi, Shimada, Ken, Sasaki, Yasutsuna
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 11.10.2016
Témata:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Disease-Free Survival Female Humans Kaplan-Meier Estimate Male Middle Aged Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Prognosis Treatment Outcome FOLFIRINOX pancreatic cancer early tumor shrinkage
ISSN:	1949-2553
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!